# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-127059
Filing Date
2024-11-14
Accepted
2024-11-14 16:10:21
Documents
42
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | kod-20240930.htm iXBRL | 10-Q | 1709305
2 | EX-31.1 | kod-ex31_1.htm | EX-31.1 | 16635
3 | EX-31.2 | kod-ex31_2.htm | EX-31.2 | 16619
4 | EX-32.1 | kod-ex32_1.htm | EX-32.1 | 10810
5 | EX-32.2 | kod-ex32_2.htm | EX-32.2 | 10802
| Complete submission text file | 0000950170-24-127059.txt |  | 4993955

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | kod-20240930.xsd | EX-101.SCH | 790704
44 | EXTRACTED XBRL INSTANCE DOCUMENT | kod-20240930_htm.xml | XML | 502822

Mailing Address 1200 PAGE MILL RD PALO ALTO CA 94304
Business Address 1200 PAGE MILL RD PALO ALTO CA 94304 650-281-0850
Kodiak Sciences Inc. (Filer) CIK: 0001468748 (see all company filings)

EIN.: 270476525 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38682 | Film No.: 241462196
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)